Please login to the form below

Not currently logged in


This page shows the latest Primaxin news and features for those working in and with pharma, biotech and healthcare.

Shionogi trumpets pneumonia data for new antibiotic cefiderocol

Shionogi trumpets pneumonia data for new antibiotic cefiderocol

Merck &Co/MSD has also set its sights on carbapenem-resistant Gram-negative pathogens with a Recarbrio, a new combination of its older Primaxin (imipenem/cilastatin) antibiotic plus a new beta

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
JPA Health Communications

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...